241 related articles for article (PubMed ID: 9860069)
1. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
Eriksson AS; Nergårdh A; Hoppu K
Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine in absence and primary generalized epilepsies.
Mikati MA; Holmes GL
J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
Smith D; Baker G; Davies G; Dewey M; Chadwick DW
Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.
Schapel GJ; Beran RG; Vajda FJ; Berkovic SF; Mashford ML; Dunagan FM; Yuen WC; Davies G
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):448-53. PubMed ID: 8505632
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
11. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.
Sander JW; Patsalos PN; Oxley JR; Hamilton MJ; Yuen WC
Epilepsy Res; 1990 Aug; 6(3):221-6. PubMed ID: 2272345
[TBL] [Abstract][Full Text] [Related]
12. [Lamotrigine in refractory partial and general epilepsies].
Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
[TBL] [Abstract][Full Text] [Related]
15. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy.
Eriksson AS; Knutsson E; Nergårdh A
Epilepsia; 2001 Feb; 42(2):230-6. PubMed ID: 11240595
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.
Boas J; Dam M; Friis ML; Kristensen O; Pedersen B; Gallagher J
Acta Neurol Scand; 1996 Oct; 94(4):247-52. PubMed ID: 8937535
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin and lamotrigine in refractory epilepsy.
Stolarek I; Blacklaw J; Forrest G; Brodie MJ
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):921-4. PubMed ID: 8057114
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
Biton V; Sackellares JC; Vuong A; Hammer AE; Barrett PS; Messenheimer JA
Neurology; 2005 Dec; 65(11):1737-43. PubMed ID: 16344515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
